![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.00 | 15.50 | 16.50 | 16.00 | 16.00 | 16.00 | 38,250 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.63 | 14.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/12/2017 11:47 | Thanks Judijudi and Nick, must have had the tremors when I typed that earlier LOL. | ![]() rafboy | |
05/12/2017 11:44 | This time next year we'll all be millionaires... no, really :) | ![]() rathean | |
05/12/2017 11:28 | Indeed Raf, todays news keeping tremors at bay! :) so long as (bright) light at end of tunnel, happy to hold... | ![]() nicktopten | |
05/12/2017 11:20 | For most long termors it is now just a waiting game I suspect. | ![]() rafboy | |
05/12/2017 11:09 | Indeed folks .. alas fully invested now from the many top up opportunities | ![]() onedayrodders | |
05/12/2017 11:04 | Imagine, Colinzeal, how it (having a CBE on board) will look even in Northern Ireland! | owenmo | |
05/12/2017 10:46 | ODR, And these foolish sellers | ![]() judijudi | |
05/12/2017 10:46 | Odr I met another Opti investor yesterday and we both agree that waiting for revenue confirmation will simply be a far higher entry point. The deals being put in place and the clues we have are like bright flashing lights. The new chairman is no lightweight brought on to add credence, he is there to take this to the next stage. Even soh recruitment has been spot on along the way. Tata rollout in new year is my bet and I still think there could be big news on a boots rollout. S | ![]() shrewdmole | |
05/12/2017 10:38 | Another huge clue for the direction this company is going. The only thing between £1+ is time. | ![]() onedayrodders | |
05/12/2017 09:59 | Per's just tweeted about today's news:Will surely support our next stages of commercial and corporate development. Looking forward to the cooperation with Neil and utilizing his wealth of experience. | ![]() parob | |
05/12/2017 09:41 | Adam Reynolds Executive Chairman of the Board Age: 53 Stephen O'Hara Chief Executive Officer, Executive Director | ![]() bobalot | |
05/12/2017 09:32 | Even i know Adam was not the ceo. | ![]() pglancy | |
05/12/2017 08:51 | Imagine how that will look to the Americans having a CBE on board. | ![]() colinzeal | |
05/12/2017 08:51 | Imagine how that will look to the Americans having a CBE on board. | ![]() colinzeal | |
05/12/2017 08:27 | OptiBiotix names food industry heavy hitter as its new chairman Life sciences group OptiBiotix Health plc (LON:OPTI) is recruiting a food industry heavy hitter to the role of chairman. Former Express Dairies and Arla Foods chief executive Neil Davidson will take over from Adam Reynolds next month. Currently a non-executive with the supermarket giant Wm Morrison (LON:MRW), he has also been an independent director at the housebuilder Persimmon (LON:PSN). It means the new boardroom hire brings with him significant FTSE 100 experience – although he also chaired AIM-quoted Produce Investments. Personal interest in innovation OptiBiotix said Davidson “has a personal interest in the development and commercialisation of technology to improve health”. That would appear to make him the ideal fit with the Opti, a pioneer of the human microbiome found in the gut. It is using its knowledge and discoveries to develop healthy sweeteners and natural alternatives to current drugs for cholesterol and diabetes. | ![]() parob | |
05/12/2017 07:57 | yes of course you are correct mouse,only just opened my eyes or it could be an age thing :) | ![]() scotty1 | |
05/12/2017 07:54 | Director share sales have to be disclosed so not AR selling. New guy has specific experience of m&a. So perhaps spring should see the purchase of bened biomedical. | ![]() mouse20 | |
05/12/2017 07:52 | Very good news,AR holds around 1.2m shares is he the one been holding the share price back with selling? | ![]() scotty1 | |
05/12/2017 07:42 | Very good news imo. AR added nothing to the core business here. | ![]() someuwin | |
05/12/2017 07:42 | There's no doubting Neil has an excellent CV with an......extensive network of industry contacts and experience in sector specific M&A transactions.All good for OPTI's next phase of development. | ![]() parob | |
05/12/2017 07:41 | Happy Chappy Mee Sen | ![]() judijudi | |
05/12/2017 07:36 | Not much reaction to this significant news. | ![]() rafboy | |
05/12/2017 07:34 | Neil looks like a good match to me (especially liking all the Dairy connections). I'm hoping with Adam Reynolds gone, TW might quieten down with his predictions now and just let things progress in their own time : )Sienna | ![]() siennadelekat21 | |
05/12/2017 07:20 | Well I think this is great news. His partner is also Anna Soubry mp, ex business minister. As an aside, where are all the contracts that we are expecting? | ![]() mouse20 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions